Trial
NCT03942419
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Eyenovia Inc.
Collaborators
—
Condition
Myopia
Intervention
Atropine 0.1% Ophthalmic Solution
Why stopped
Interim Analysis reviewed by Data Monitoring Committee indicated futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-06